Arch Grants

Pro-Arc Diagnostics


Home | Browse

  • Origin: MO
  • Grant awarded in: 2016

Involved Industries:


Contact Information

Website

 


Support Organizations:


What is Pro-Arc Diagnostics?


Pro-Arc Diagnostics is a developing next-generation laboratory test for patients at risk of Progressive Multifocal Leukoencephalopathy (PML). PML is caused by the John Cunningham Virus and is responsible for thousands of deaths each year. To date, doctors have had no way to determine which patients were at risk for developing PML. Pro-Arc’s technology is being designed to identify these patients, which may eventually allow doctors to monitor PML risk and safely design treatment courses in response.


Company Leadership


Michelle Faits

Michelle Faits is the Co-Founder and Chief Executive Officer of Pro-Arc Diagnostics, a 2016 Arch Grants Recipient.

Michelle is a Ph.D. scientist and a 2016 Pipeline Fellow and Associate Entrepreneur with the BioSTL Fundamentals program.


Dana Watt

Dana Watt is the Co-Founder and Chief Scientific Officer of Pro-Arc Diagnostics, a 2016 Arch Grants Recipient.

Dana is a Ph.D. scientist and a Postdoctoral Fellow in Accelerated Innovation at the Skandalaris Center at Washington University in St. Louis.


James Sorrell

James Sorrell is the Co-Founder and Chief Financial Officer of Pro-Arc Diagnostics, a 2016 Arch Grants Recipient.

James has a background as a Venture Analyst at the Skandalaris Center, and is the former IT Director and Consultant with the BALSA Group.


Chris Bethel

Chris Bethel is the Advisor of Pro-Arc Diagnostics, a 2016 Arch Grants Recipient.

Chris bring over 10 years of experience developing highly sensitive analytical methods in regulated environments to the Pro-Arc team, including extensive technical expertise in the analytical technique which the Pro-Arc's tech is built upon.



Similar Startups

Other companies you might be interested in: